PROSPECTUS SUPPLEMENT
(to the Prospectus, dated January 7, 1993)
IMMUNOMEDICS, INC.
3,000,000 Shares
Common Stock, $. 01 Par Value
This Prospectus Supplement constitutes an essential part of
the Prospectus, dated January 7, 1993, of Immunomedics, Inc.
and should be read in conjunction with such Prospectus.
The information set forth below supersedes the information
contained under "Selling Stockholders" in the Prospectus.
All capitalized terms used herein have the meanings given
such terms in the Prospectus.
SELLING STOCKHOLDERS
The shares of Common Stock to which this Prospectus
relates are being registered for reoffers and resales by
Selling Stockholders of the Company who may acquire such
shares pursuant to the exercise of options granted or to be
granted under the Plan. The Selling Stockholders named below
may resell all, a portion, or none of the shares that they
acquire or may acquire pursuant to the exercise of options
under the Plan.
Participants under the Plan who are deemed to be
"affiliates" of the Company who acquire Common Stock under
the Plan may be added to the Selling Stockholders listed
below from time to time, either by means of a post-effective
amendment to the Registration Statement or by use of a
prospectus supplement filed pursuant to Rule 424(c) under the
1933 Act . An "affiliate" is defined in Rule 405 under the
1933 Act as a "person that directly, or indirectly, through
one or more intermediaries, controls, or is controlled by,
or is under common control with", the Company.
<PAGE>
The following table sets forth certain information
concerning the Selling Stockholders as of the date of this
Prospectus. Except as disclosed in the table, none of the
Selling Stockholders listed below has, or within the past
three years has had, any position, office or other material
relationship with the Company or any of its predecessors or
affiliates.
Maximum Number of
Shares Subject to
Outstanding Options
Position With Which May Be
Name The Company Reoffered Hereby (1)
- ---------------------- ------------------------ --------------------
David M. Goldenberg Chairman of the Board, 175,000
Chief Executive Officer
and Director
Albert D. Angel Director 30,000
A. E. Cohen Director 30,000
Marvin E. Jaffe Director 20,000
Richard R. Pivirotto Director 30,000
Warren W. Rosenthal Director 30,000
Richard C. Williams Director 30,000
Amy Factor Executive Vice President 285,000
Secretary and Treasurer
Hans J. Hansen Vice President - 205,000
Research and Development
Carl M. Pinsky Vice President - 175,000
Medical Affairs
(1) As of September 30, 1995. Does not constitute a commitment
to sell any or all of the stated number of shares of Common
Stock. The number of shares offered shall be determined from
time to time by each Selling Stockholder at his or her sole
discretion.
The date of the Prospectus Supplement is October 16, 1995
